Executive Summary
On January 21, 2026, 26 8-K filings showed a dominant pattern of neutral earnings disclosures (Item 2.02) from financial institutions like Truist, Citizens Financial, Ally, and Fulton, with no disclosed metrics limiting directional insights; Johnson & Johnson provided the sole healthcare-relevant filing, a high-materiality neutral results release. Cross-filing analysis reveals low overall sentiment and materiality, except for UMeWorld's critical bearish delisting notice, indicating minimal systemic shocks to S&P 500 Healthcare. Portfolio implications are negligible for healthcare investors, as non-healthcare filings (financials heavy) suggest broader market earnings cadence without sector-specific correlations or alpha triggers.
Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from January 19, 2026.
Investment Signals(4)
- UMeWorld Inc.β(BEARISH)β²
Notice of delisting, failure to meet listing standards, and governance changes signal severe distress
- Johnson & Johnson (JNJ)β(BULLISH)β²
High-materiality Q4 earnings release amid neutral sentiment, potential for sector benchmark if details beat expectations
- Oportun Financial Corpβ(BULLISH)β²
Officer change paired with earnings may indicate positive succession planning
- Pinnacle Financial Partnersβ(BULLISH)β²
Multi-item earnings with Reg FD disclosure, potential upside if exhibits show strength
Risk Flags(3)
- UMeWorld Inc./Delistingβ(CRITICAL)βΌ
Critical risk from notice of listing failure, bylaws changes, and undisclosed events threatening viability
- Multiple Financials (Truist, Citizens, Ally)/Earnings UncertaintyβΌ
High-materiality results without metrics heightens assessment risk, potential indirect drag on healthcare financing
- Officer Changes (Zeo ScientifiX, Oportun, First American)/GovernanceβΌ
Undisclosed leadership shifts in several firms raise operational continuity concerns
Opportunities(3)
High-materiality Item 2.02 disclosure offers alpha if pharma results exceed consensus, setting healthcare tone
- Financial Cluster (Truist, Citizens, Fulton)/Sector Stabilityβ
Neutral earnings wave from banks could signal lending resilience, supporting healthcare M&A/debt financing
Potential internal promotion in succession provides governance stability play
Sector Themes(3)
- Earnings Blackout Neutralityβ
15+ filings with Item 2.02 but no metrics across financials and J&J indicate standard reporting season start, low volatility for healthcare portfolios
- Leadership Fluxβ
Recurring officer changes (Zeo, Oportun, NYT, First American) without details suggest routine transitions, minimal sector contagion
- Compliance Outlierβ
Isolated delisting (UMeWorld) amid otherwise stable disclosures flags micro-cap risks irrelevant to S&P 500 Healthcare
Watch List(4)
- π
Monitor delisting progression, fiscal year changes, and Reg FD impacts for short-side opportunities
Track full earnings exhibits for revenue/earnings beats in pharma/devices amid neutral summary
- Financial Earnings Cluster (Truist, Citizens, Ally)π
Watch for disclosed metrics influencing broader market sentiment and healthcare funding costs
- Officer Change Filers (Zeo ScientifiX, Oportun)π
Follow-up on positions/reasons for potential governance ripple effects
Filing Analyses(26)
21-01-2026
Zeo ScientifiX, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001829126-26-000431, Size: 183 KB) disclosing an officer change under Item 5.02, which covers departures or appointments of directors or certain officers, or compensatory arrangements. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are provided in the filing summary. This event is classified as NEUTRAL with no directional investment bias due to lack of disclosed facts.
21-01-2026
NewtekOne, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001628280-26-002929, Size: 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed results are disclosed in the provided filing summary. Sector not specified.
21-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001493152-26-002959, Size: 224 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative metrics, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
21-01-2026
News Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001564708-26-000013, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are provided in the filing summary. Sector not specified.
21-01-2026
Truist Financial Corp filed an 8-K on January 21, 2026 (AccNo: 0000092230-26-000023, Size: 6 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing announcing financial results. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
21-01-2026
Citizens Financial Group Inc/RI filed an 8-K on January 21, 2026 (AccNo: 0000759944-26-000017, Size: 17 MB), reporting under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific numerical financial metrics, transaction values, or detailed outcomes provided in the filing summary. Sector not specified.
21-01-2026
Beneficient filed a Form 8-K on January 21, 2026 (AccNo: 0001493152-26-002993, Size: 295 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or named entities beyond the filer are disclosed in the provided filing summary. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.
21-01-2026
Johnson & Johnson filed an 8-K on January 21, 2026 (AccNo: 0000200406-26-000002, size 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific numerical financial metrics, transaction values, or detailed data are mentioned in the provided filing information. Sector is not specified.
21-01-2026
Ally Financial Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-017242, Size: 27 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned in the provided filing summary.
21-01-2026
UMeWorld Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0001477932-26-000290), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard/transfer of listing. Additional items include Item 5.03 (amendments to articles of incorporation or bylaws/change in fiscal year), Item 7.01 (Regulation FD disclosure), Item 8.01 (other events), and Item 9.01 (financial statements and exhibits). No quantitative data, transaction details, or specific reasons are disclosed.
21-01-2026
CION Investment Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001104659-26-005253, Size: 263 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other numerical data are mentioned.
21-01-2026
CITY HOLDING CO filed an 8-K on January 21, 2026 (AccNo: 0000726854-26-000005, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings release disclosure.
21-01-2026
MUNCY COLUMBIA FINANCIAL Corp filed an 8-K on January 21, 2026 (AccNo: 0001174947-26-000064, Size: 335 KB) announcing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 includes financial statements and exhibits. No specific parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary.
21-01-2026
River Financial Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-017699), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
21-01-2026
NVE CORP /NEW/ filed an 8-K on January 21, 2026 (AccNo: 0001376474-26-000058, Size: 261 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 8.01 Other Events. This is a financial results disclosure from the US market with sector not specified. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary.
21-01-2026
Society Pass Incorporated filed a Form 8-K on January 21, 2026 (AccNo: 0001493152-26-003083, file size 17 MB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details on the agreement, counterparties, transaction value, or financial impacts are provided.
21-01-2026
Oportun Financial Corp filed an 8-K on 2026-01-21 (AccNo: 0001193125-26-017944, Size: 331 KB) disclosing an officer change under Item 5.02, along with results of operations and financial condition (Item 2.02) and financial statements/exhibits (Item 9.01). Event type is Officer Change dated January 21, 2026, sourced from US SEC. No specific details on the officer, position, appointment/resignation, or reasons provided in the summary.
21-01-2026
EAGLE FINANCIAL SERVICES INC filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-017913, Size: 156 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
21-01-2026
FB Financial Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001649749-26-000003), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.
21-01-2026
New York Times Co filed an 8-K on January 21, 2026 (AccNo: 0000071691-26-000003, Size: 438 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment/resignation), reasons, or quantitative data are provided. Sector is not specified.
21-01-2026
Costco Wholesale Corp filed a Form 8-K on January 21, 2026 (AccNo: 0000909832-26-000016, Size: 184 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 8.01 (Other Events). No specific details on vote results, other events, transaction values, or financial metrics are disclosed in the provided filing summary. Sector not specified.
21-01-2026
First American Financial Corp filed a Form 8-K on January 21, 2026 (AccNo: 0001193125-26-017981, Size: 148 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, appointment/resignation, or reasons are provided in the summary.
21-01-2026
Pinnacle Financial Partners, Inc. filed a Form 8-K on January 21, 2026 (AccNo: 0002082866-26-000008, Size: 16 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.
21-01-2026
CACI International Inc./DE/ filed a Form 8-K on January 21, 2026 (AccNo: 0001628280-26-002895, Size: 584 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC with no sector specified. No specific financial metrics, transaction details, or numerical data are disclosed in the provided filing summary.
21-01-2026
FULTON FINANCIAL CORP filed an 8-K on January 21, 2026 (AccNo: 0000700564-26-000002, Size: 6 MB) reporting Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits. This is a standard financial results disclosure with no specific revenue, earnings, or transaction details provided. All quantitative financial metrics are NOT_DISCLOSED.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 26 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC